Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UNC5B-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100506735 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEFB125 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZDHHC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1QA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF267 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHMP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VRK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105373460 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACSM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17RD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on